Type III IFNs: New layers of complexity in innate antiviral immunity

被引：77

作者：

Ank, Nina ^{[1
]}

Paludan, Soren R. ^{[1
]}

机构：

[1] Univ Aarhus, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark

来源：

BIOFACTORS | 2009年 / 35卷 / 01期

关键词：

Type III interferon; virus infections innate immunity; C VIRUS-REPLICATION; HERPES-SIMPLEX-VIRUS; ANTITUMOR-ACTIVITY; VIRAL-INFECTIONS; IN-VIVO; LAMBDA; INTERFERONS; CELLS; RECOGNITION; CYTOKINES;

D O I：

10.1002/biof.19

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cytokines are small secreted molecules, which mediated cross-talk between cells involved in the immune response Interferon's (IFN)s, constitute a class of cytokines antiviral activities, and the type I IFNs have been ascribed particularly important roles in, the innate antiviral response Type III IFNs.(also known as IFN-lambda or interleukin 28/29) represent a class of novel cytokines with biological activities similar to the type I IFNs, but seem to have a more specialized role in antiviral defense by exerting host-protection primarily at epithelial surfaces. In this review, we describe the current knowledge on the role of type III IFNS in antiviral defense.(C) 2009 International Union of Biochemistry and Molecular Biology, Inc. Volume 35, Number 1, January/February 2009, Pages 82-87. E-mail: srp@microbiology.au.dk

引用

页码：82 / 87

页数：6

共 45 条

[1] Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo [J].

Ank, N ;

West, H ;

Bartholdy, C ;

Eriksson, K ;

Thomsen, AR ;

Paludan, SR .

JOURNAL OF VIROLOGY, 2006, 80 (09) :4501-4509

[2] An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity [J].

Ank, Nina ;

Iversen, Marie B. ;

Bartholdy, Christina ;

Staeheli, Peter ;

Hartmann, Rune ;

Jensen, Uffe B. ;

Dagnaes-Hansen, Frederik ;

Thomsen, Allan R. ;

Chen, Zhi ;

Haugen, Harald ;

Klucher, Kevin ;

Paludan, Soren R. .

JOURNAL OF IMMUNOLOGY, 2008, 180 (04) :2474-2485

[3] IFN-λ:: Novel antiviral cytokines [J].

Ank, Nina ;

West, Hans ;

Paludan, Soren R. .

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2006, 26 (06) :373-379

[4] Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model [J].

Bartlett, NW ;

Buttigieg, K ;

Kotenko, SV ;

Smith, GL .

JOURNAL OF GENERAL VIROLOGY, 2005, 86 :1589-1596

[5] Role of deficient type III interferon-λ production in asthma exacerbations [J].

Contoli, Marco ;

Message, Simon D. ;

Laza-Stanca, Vasile ;

Edwards, Michael R. ;

Wark, Peter A. B. ;

Bartlett, Nathan W. ;

Kebadze, Tatiana ;

Mallia, Patrick ;

Stanciu, Luminita A. ;

Parker, Hayley L. ;

Slater, Louise ;

Lewis-Antes, Anita ;

Kon, Onn M. ;

Holgate, Stephen T. ;

Davies, Donna E. ;

Kotenko, Sergei V. ;

Papi, Alberto ;

Johnston, Sebastian L. .

NATURE MEDICINE, 2006, 12 (09) :1023-1026

[6] The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain [J].

Donnelly, RP ;

Sheikh, F ;

Kotenko, SV ;

Dickensheets, H .

JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (02) :314-321

[7] Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes [J].

Doyle, Sean E. ;

Schreckhise, Heidi ;

Khuu-Duong, Kien ;

Henderson, Katherine ;

Rosler, Robert ;

Storey, Harold ;

Yao, Lena ;

Liu, Hong ;

Barahmand-pour, Fariba ;

Sivakumar, Pallavur ;

Chan, Chung ;

Birks, Carl ;

Foster, Don ;

Clegg, Christopher H. ;

Wietzke-Braun, Perdita ;

Mihm, Sabine ;

Klucher, Kevin M. .

HEPATOLOGY, 2006, 44 (04) :896-906

[8] Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1 -: Similarities with type I interferon signaling [J].

Dumoutier, L ;

Tounsi, A ;

Michiels, T ;

Sommereyns, C ;

Kotenko, SV ;

Renauld, JC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :32269-32274

[9] Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency [J].

Dupuis, S ;

Jouanguy, E ;

Al-Hajjar, S ;

Fieschi, C ;

Al-Mohsen, IZ ;

Al-Jumaah, S ;

Yang, K ;

Chapgier, A ;

Eidenschenk, C ;

Eid, P ;

Al Ghonaium, A ;

Tufenkeji, H ;

Frayha, H ;

Al-Gazlan, S ;

Al-Rayes, HA ;

Schreiber, RD ;

Gresser, I ;

Casanova, JL .

NATURE GENETICS, 2003, 33 (03) :388-391

[10] Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].

Durbin, JE ;

Hackenmiller, R ;

Simon, MC ;

Levy, DE .

CELL, 1996, 84 (03) :443-450

← 1 2 3 4 5 →